Brigid Quinn (MEDIA ONLY)
The United States Patent and Trademark Office (USPTO) will hold symposiums in Washington and California on current patent examination practices in biotechnology and software. The one-day sessions will also focus on new USPTO procedures implementing provisions of the American Inventors Protection Act (AIPA).
"USPTO's west coast symposiums are designed to help those who use our patent system understand the agency's rules and practices in the new genetic and information technologies," said Q. Todd Dickinson, Under Secretary of Commerce and Director of the U.S. Patent and Trademark Office. "The sessions will also help patent practitioners and independent inventors understand the impact of the AIPA, which contains the most far-reaching changes to the U.S. patent system in nearly 50 years."
Biotechnology will be the main focus of the symposiums and these sessions will cover a wide variety of issues, including applications of recent changes in written description and utility guidelines. Patenting of genes, gene therapy, transgenic animals, expressed sequence tags, antisense oligonucleotides and single nucleotide polymorphisms will also be among the items covered.
The software segment will focus on computer-related inventions, including business methods. The AIPA session will focus on new USPTO procedures implementing requests for continued examination, patent term adjustment, eighteen-month publication; and inter partes reexamination. Panelists are USPTO experts in biotechnology, computers, electronics and computer software technologies.
Monday, September 18 in Seattle
Wednesday, September 20 in Millbrae, Calif.
Thursday, September 21 in La Jolla, Calif.
For more information, or to register for the symposiums, please go to http://www.uspto.gov/web/offices/ac/ahrpa/opa/rshow0900.html
- # # # -